Fracture risk in men with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra 223)

被引：0
|
作者：
Hijab, A. [1 ]
Tunariu, N. [2 ]
Tovey, H. [3 ]
Alonzi, R. [4 ]
Tree, A. [1 ]
Staffurth, J. [5 ]
Blackledge, M. [6 ]
Padhani, A. R. [7 ]
Stidwill, H. [1 ]
Finch, J. [4 ]
Chatfield, P. [3 ]
Perry, S. [3 ]
Koh, D-M. [2 ]
Hall, E. [3 ]
Parker, C. [1 ]
机构：
[1] Royal Marsden NHS Fdn Trust, Inst Canc Res, Acad Urol Unit, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Inst Canc Res, Radiol, Sutton, Surrey, England
[3] Royal Marsden NHS Fdn Trust, Inst Canc Res, Clin Trials Unit, Sutton, Surrey, England
[4] Mt Vernon Canc Ctr, Urooncol, London, England
[5] Velindre Canc Ctr, Radiotherapy, Cardiff, Wales
[6] Royal Marsden NHS Fdn Trust, Inst Canc Res, Radiotherapy & Imaging, Sutton, Surrey, England
[7] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Radiol, Northwood, Middx, England
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.931
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
672P
引用
收藏
页码：S539 / S539
页数：1
相关论文
共 50 条
  • [31] Radium-223 for the treatment of metastatic castration-resistant prostate cancer: A window of opportunity
    Gomez-Veiga, F.
    Alvarez-Ossorio, J. L.
    Carballido-Rodriguez, J.
    Juarez-Soto, A.
    Rodriguez-Antolin, A.
    Cozar-Olmo, J. M.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (10): : 616 - 624
  • [32] Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer
    Peters, Michel L.
    de Meijer, Claudine
    Wyndaele, Dirk
    Noordzij, Walter
    Leliveld-Kors, Annemarie M.
    van den Bosch, Joan
    van den Berg, Pieter H.
    Baka, Agni
    Gaultney, Jennifer G.
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2018, 16 (01) : 133 - 143
  • [33] Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging
    Iizuka, Junpei
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 16 - 23
  • [34] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Du, Yong
    Carrio, Ignasi
    De Vincentis, Giuseppe
    Fanti, Stefano
    Ilhan, Harun
    Mommsen, Caroline
    Nitzsche, Egbert
    Sundram, Francis
    Vogel, Wouter
    Oyen, Wim
    Lewington, Val
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
  • [35] FDG PET/CT as a tool to provide the prognostic stratification and response assessment of metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride (Ra-223)
    Bauckneht, M.
    Capitanio, S.
    Fornarini, G.
    Ceriani, V.
    Ippoliti, M.
    Ciarmiello, A.
    Giovacchini, G.
    Bongioanni, F.
    Piccardo, E.
    Agnese, G.
    Di Ciolo, L.
    Sambuceti, G.
    Morbelli, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S527 - S528
  • [36] A phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)
    Petrylak, D. P.
    Vaishampayan, U. N.
    Patel, K. R.
    Higano, C. S.
    Albany, C.
    Dawson, N. A.
    Mehlhaff, B. A.
    Quinn, D. I.
    Nordquist, L. T.
    Wagner, V. J.
    Shen, J.
    Trandafir, L.
    Sartor, O.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 340 - 341
  • [37] The Timing of Radium-223 Therapy in Castration-Resistant Prostate Cancer
    Sartor, Oliver
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (09) : 570 - 572
  • [38] Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer
    Parimi, Sunil
    Bondy, Suraya
    Tsang, Erica
    McKenzie, Michael Ross
    Bachand, Francois
    Aparicio, Maria
    Duncan, Graeme
    Sunderland, Katherine
    Olson, Robert Anton
    Pai, Howard Huaihan
    Alexander, Abraham Skaria
    LaPointe, Vincent
    Chi, Kim N.
    Tyldesley, Scott
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2019, 13 (10): : E311 - E316
  • [39] Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
    Caffo, Orazio
    Frantellizzi, Viviana
    Tucci, Marcello
    Galli, Luca
    Monari, Fabio
    Baldari, Sergio
    Masini, Cristina
    Bortolus, Roberto
    Facchini, Gaetano
    Alongi, Pierpaolo
    Agostini, Stefania
    Zichi, Clizia
    Biasco, Elisa
    Fanti, Stefano
    Pignata, Salvatore
    Filice, Angelina
    Borsatti, Eugenio
    Rossetti, Sabrina
    Spada, Massimiliano
    Cortesi, Enrico
    De Vincentis, Giuseppe
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (11) : 2633 - 2638
  • [40] Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223
    Orazio Caffo
    Viviana Frantellizzi
    Marcello Tucci
    Luca Galli
    Fabio Monari
    Sergio Baldari
    Cristina Masini
    Roberto Bortolus
    Gaetano Facchini
    Pierpaolo Alongi
    Stefania Agostini
    Clizia Zichi
    Elisa Biasco
    Stefano Fanti
    Salvatore Pignata
    Angelina Filice
    Eugenio Borsatti
    Sabrina Rossetti
    Massimiliano Spada
    Enrico Cortesi
    Giuseppe De Vincentis
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2633 - 2638
12345